top of page

The Extraordinary General Meeting was adjourned to February 3, 2025 due to lack of quorum

Givol Moked01
Jan 27
0 min read

Recent Posts

Form 6-K- Financial and operating results for the first half of 2025

Form 6-K- Financial and operating results for the first half of 2025

Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands

Strategic Acquisition of ISHI, Unlocking Access to Premium U.S. Cannabis Technology and Brands

Form 6-K-InterCure Announces FY2024 Results and Provides Q1 2025 Update:Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million,Strong Start to 2025

Form 6-K-InterCure Announces FY2024 Results and Provides Q1 2025 Update:Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million,Strong Start to 2025

bottom of page